Peptide Injections

3

5 Vial/Vials

1 Box/Boxes

5000 , Piece/Pieces

Peptide deficiency, muscle wasting, tissue repair needs

Hypoprothrombinemia, Vitamin K Deficiency

Other, Allopathic

Injection

Intramuscular or subcutaneous injection

Dosage Guidelines Administration: Subcutaneous injection (not IV or IM). Starting dose (adults): -thalassemia: 1 mg/kg once every 3 weeks. Myelodysplastic syndromes (MDS): 1 mg/kg once every 3 weeks. Adjustment: If response is inadequate, dose may be increased to 1.25 mg/kg (maximum). Dose interruptions or reductions may be required for side effects (e.g., high hemoglobin, hypertension, bone pain). Treatment goal: Reduce or eliminate the need for red blood cell transfusions. Reconstitution: Each vial must be reconstituted with sterile water before injection

1000 Per Month

100 Per Day